Cano Health, Inc.

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Purchased

Purchase Date

Estimated Loss

The submission of this form does not create an attorney-client relationship.

Investigation Details

On November 17, 2023, UBS cut its rating of Cano Health to “Sell”, citing the Company’s deteriorating liquidity position. UBS opined that “elevated third-party medical expenses will have a sustained negative effect on the company’s already challenged liquidity position.”

On this news, Cano’s stock price fell 6.72%, to close at $7.63 per share on November 17, 2023.